Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.59
+0.13008.90%
Post-market: 1.590.00000.00%16:00 EDT
Volume:17.99K
Turnover:28.07K
Market Cap:16.18M
PE:-1.02
High:1.62
Open:1.50
Low:1.50
Close:1.46
Loading ...

Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs

Reuters
·
Yesterday

BRIEF-Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza Strain

Reuters
·
29 May

Cocrystal Pharma’s Investigational Drug Candidate Cc-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5n1 Avian Influenza Strain

THOMSON REUTERS
·
29 May

Cocrystal Pharma (COCP) Gets a Buy from Noble Financial

TIPRANKS
·
19 May

Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Cocrystal Pharma Q1 EPS $(0.23) Beats $(0.51) Estimate

Benzinga
·
15 May

BRIEF-Cocrystal Pharma Q1 Net Income USD -2.301 Million

Reuters
·
15 May

Cocrystal Pharma Q1 Basic EPS USD -0.23

THOMSON REUTERS
·
15 May

Cocrystal Pharma Q1 Operating Expenses USD 2.341 Million

THOMSON REUTERS
·
15 May

Cocrystal Pharma Inc expected to post a loss of 50 cents a share - Earnings Preview

Reuters
·
09 May

Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

GlobeNewswire
·
24 Apr

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

GlobeNewswire
·
16 Apr

COCP: Norovirus Challenge Study Planned for 2025…

Zacks Small Cap Research
·
01 Apr

BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million

Reuters
·
31 Mar

Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on Its Antiviral Drug-Development Programs

THOMSON REUTERS
·
31 Mar

Cocrystal Pharma FY Operating Income USD -17.878 Million

THOMSON REUTERS
·
31 Mar

Cocrystal Pharma Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
24 Mar

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
14 Mar

Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch

Simply Wall St.
·
12 Feb

Cocrystal Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Jan